Need Regulatory Help? Try Our Platform
Post your regulatory questions or request quotations from verified pharmaceutical consultants worldwide. Get matched with experts who specialize in your market.
January 18, 2026
Approximately 5 minutes
Passing Preliminary Assessment for Medical Device Applications – TGA Process
Passing Preliminary Assessment for Medical Device Applications – TGA Process
Purpose of Preliminary Assessment
The preliminary assessment is the first formal check performed by the TGA after an application for conformity assessment or ARTG inclusion is lodged. Its primary objectives are to:
- Confirm the application is complete and correctly formatted.
- Verify basic eligibility and compliance with lodgement requirements.
- Identify obvious deficiencies early to avoid unnecessary full reviews.
Passing this stage does not indicate that the application will ultimately be approved; it only means it meets threshold requirements to proceed to technical evaluation. Source: Passing preliminary assessment for medical device applications - TGA
Key Elements Checked During Preliminary Assessment
The TGA examines several critical aspects:
- Correct Application Type and Fees: Confirmation that the application matches the intended regulatory pathway and that appropriate fees have been paid.
- Completeness of Submission: All required modules, forms, declarations, and supporting documents are present.
- Format and Structure: Application follows TGA-specified structure, file naming conventions, and electronic submission requirements.
- Device Description and Classification: Basic consistency between claimed classification, intended purpose, and GMDN code.
- Essential Principles Declaration: Presence of a valid declaration of conformity to Essential Principles.
- Conformity Assessment Evidence: Inclusion of required certificates or reports (e.g., ISO 13485, EU certificates where applicable).
- Australian Sponsor Details: Valid sponsor information and authorisation.
Applications are not assessed for scientific/technical merit at this stage.
Outcomes of Preliminary Assessment
- Pass: The application proceeds to full technical evaluation. Sponsors receive confirmation and an estimated review timeline.
- Fail: The TGA issues a 'Notification of Deficiencies' detailing reasons for failure. The application is not accepted for review. Sponsors may:
- Withdraw and re-lodge a corrected version (new fees apply).
- Request reconsideration in limited circumstances.
- Proceed to appeal processes if applicable.
Common failure reasons include missing documents, incorrect fees, incomplete declarations, or mismatched classification claims.
Practical Tips for Sponsors
- Use TGA checklists and templates to ensure all required elements are included.
- Double-check file formats, sizes, and naming conventions before lodgement.
- Verify that all declarations are signed and dated correctly.
- Confirm payment of correct fees based on device classification and application type.
- Consider requesting a pre-submission meeting for complex applications to clarify requirements in advance.
The TGA provides detailed checklists, common deficiency examples, lodgement guides, and step-by-step instructions to help sponsors prepare applications likely to pass preliminary assessment. Source: Passing preliminary assessment for medical device applications - TGA
Passing preliminary assessment is a critical gateway that significantly improves the likelihood of a smooth and timely full review process for medical device market authorisation in Australia.
Ask Anything
We'll follow up with you personally.
Related Articles
Approximately 5 minutes
Consent to Supply Medical Devices Not Meeting Essential Principles – TGA Transitional Provisions
During the EU MDR transition period, the Therapeutic Goods Administration (TGA) may grant consent under section 41HB of the Therapeutic Goods Act 1989 for certain medical devices that do not fully comply with the current Australian Essential Principles, provided they hold valid MDD/AIMDD certification with extended transitional validity and meet strict conditions to prevent shortages while maintaining safety.
Approximately 5 minutes
Determining If Your Product Is a Medical Device Requiring ARTG Inclusion – TGA Guidance
The Therapeutic Goods Administration (TGA) provides a step-by-step decision-making process to determine whether a product meets the definition of a medical device under Australian law and therefore requires inclusion in the Australian Register of Therapeutic Goods (ARTG) before supply, covering key criteria such as intended purpose, principal intended action, and exclusions for certain borderline products.
Approximately 5 minutes
Medical Device Regulatory Engagement Meetings – TGA Pre-Submission Process
The Therapeutic Goods Administration (TGA) offers formal pre-submission regulatory engagement meetings to facilitate early dialogue with sponsors on complex medical device applications, helping to clarify regulatory requirements, discuss development plans, and resolve potential issues before formal lodgement, thereby improving application quality and review efficiency.
Approximately 5 minutes
Supplying Medical Devices in Australia – TGA Regulatory Requirements
Medical devices can only be lawfully supplied in Australia if they are included in the Australian Register of Therapeutic Goods (ARTG), unless subject to specific exemptions or special access schemes. Sponsors must ensure ongoing compliance with post-market obligations, including vigilance reporting, recalls, and advertising rules, to maintain legal supply throughout the product lifecycle.